Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 125 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Tsolaki, Magda [Clear All Filters]
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease..
Ann N Y Acad Sci. 1180, 36-46.
(2009). Alzheimer's dementia and post-traumatic stress disorder differences and similarities in neuroimaging..
Hell J Nucl Med. 12(1), 41-6.
(2009). Attitudes and perceptions regarding Alzheimer's disease in Greece..
Am J Alzheimers Dis Other Demen. 24(1), 21-6.
(2009). CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment..
JAMA. 302(4), 385-93.
(2009). Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease..
J Neurol. 256(5), 758-67.
(2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease..
Nat Genet. 41(10), 1088-93.
(2009). Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease..
Int J Neurosci. 119(6), 765-77.
(2009). Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey..
Curr Med Res Opin. 25(12), 3059-68.
(2009). MRI measures of Alzheimer's disease and the AddNeuroMed study..
Ann N Y Acad Sci. 1180, 47-55.
(2009). Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study..
Lancet Neurol. 8(7), 619-27.
(2009). Rivastigmine for Alzheimer's disease..
Cochrane Database Syst Rev. CD001191.
(2009). Severe psychological stress in elderly individuals: a proposed model of neurodegeneration and its implications..
Am J Alzheimers Dis Other Demen. 24(2), 85-94.
(2009). Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's disease..
Neurobiol Aging. 31(8), 1375-85.
(2010). APOE ε2 allele is associated with larger regional cortical thicknesses and volumes..
Dement Geriatr Cogn Disord. 30(3), 229-37.
(2010). Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease..
Arch Gen Psychiatry. 67(7), 739-48.
(2010). CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study..
J Alzheimers Dis. 22(4), 1089-97.
(2010). Cerebrospinal fluid proteins in the diagnosis of Alzheimer's disease..
Recent Pat CNS Drug Discov. 5(2), 172-8.
(2010). Depression, extrapyramidal symptoms, dementia and an unexpected outcome: a case report..
Cases J. 3, 47.
(2010). Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease..
CNS Neurosci Ther. 16(4), 246-53.
(2010). Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study..
J Alzheimers Dis. 21(3), 947-66.
(2010). Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial..
Lancet Neurol. 9(10), 969-77.
(2010). Severely stressful events and dementia: a study of an elderly Greek demented population..
Psychiatry Res. 176(1), 51-4.
(2010). AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America..
Neuroimage. 58(3), 818-28.
(2011). The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months..
Int J Geriatr Psychiatry. 26(1), 75-82.
(2011). Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment..
Neuroimage. 56(1), 212-9.
(2011).